T Cell Counts in Peripheral Blood at Leukapheresis Predict Responses to Subsequent CAR-T Cell Therapy

Scientists evaluated the clinical impact of CD3+ cell count in peripheral blood at leukapheresis on clinical outcomes of CAR-T cell therapy.